“…The syphilitic chancre usually presents as an indurated, painless ulcer. 3 Case two showed more typical presentations of early latent syphilis in the form of a white patch and case three mucocutaneous …”
Section: Clinical Presentation Of Syphilis: Extra-oralmentioning
confidence: 94%
“…The risk of infectivity and clinical features are closely linked to the stage of the disease. 2,3,8 Clinical presentation of syphilis: intra-oral…”
Section: Clinical Presentation Of Syphilis: Extra-oralmentioning
confidence: 99%
“…3 The presenting lesion in case two: a non-specific well demarcated white patch on the lateral border of the tongue affects the tongue, palate, gingiva or lips and has a spontaneous resolution. 3 The secondary stage of the disease is characterised by snail track ulceration. Lues maligna also known as malignant syphilis is a rare manifestation of secondary syphilis which can involve the oral mucosa.…”
Section: Clinical Presentation Of Syphilis: Extra-oralmentioning
confidence: 99%
“…3 Secondary syphilis Raised lesions with a pseudomembrane surrounded by erythema (mucous patches) and/or snail track oral mucosal ulceration and regional lymphadenopathy. 3 Latent syphilis Often has no clinical manifestations. However, so-called mucocutaneous relapse with nonspecific oral mucosal white patches may occur.…”
Section: Stage Of Infection Intraoral Manifestationsmentioning
confidence: 99%
“…2 Possible reasons for this increase in prevalence are a false sense of security that today sexually transmitted infections are curable, resulting in an increase in sexual promiscuity and alcohol abuse, and a decrease in the use of barrier protection and lack of pertinent knowledge. 3 Syphilis is an infectious disease caused by the organism Treponema pallidum. There has been a dramatic increase in the number of new cases of syphilis in the UK over the past decade.…”
“…The syphilitic chancre usually presents as an indurated, painless ulcer. 3 Case two showed more typical presentations of early latent syphilis in the form of a white patch and case three mucocutaneous …”
Section: Clinical Presentation Of Syphilis: Extra-oralmentioning
confidence: 94%
“…The risk of infectivity and clinical features are closely linked to the stage of the disease. 2,3,8 Clinical presentation of syphilis: intra-oral…”
Section: Clinical Presentation Of Syphilis: Extra-oralmentioning
confidence: 99%
“…3 The presenting lesion in case two: a non-specific well demarcated white patch on the lateral border of the tongue affects the tongue, palate, gingiva or lips and has a spontaneous resolution. 3 The secondary stage of the disease is characterised by snail track ulceration. Lues maligna also known as malignant syphilis is a rare manifestation of secondary syphilis which can involve the oral mucosa.…”
Section: Clinical Presentation Of Syphilis: Extra-oralmentioning
confidence: 99%
“…3 Secondary syphilis Raised lesions with a pseudomembrane surrounded by erythema (mucous patches) and/or snail track oral mucosal ulceration and regional lymphadenopathy. 3 Latent syphilis Often has no clinical manifestations. However, so-called mucocutaneous relapse with nonspecific oral mucosal white patches may occur.…”
Section: Stage Of Infection Intraoral Manifestationsmentioning
confidence: 99%
“…2 Possible reasons for this increase in prevalence are a false sense of security that today sexually transmitted infections are curable, resulting in an increase in sexual promiscuity and alcohol abuse, and a decrease in the use of barrier protection and lack of pertinent knowledge. 3 Syphilis is an infectious disease caused by the organism Treponema pallidum. There has been a dramatic increase in the number of new cases of syphilis in the UK over the past decade.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.